These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25065938)

  • 1. Plasma Pentraxin 3 as a biomarker of metabolic syndrome.
    Kardas F; Akın L; Kurtoglu S; Kendirci M; Kardas Z
    Indian J Pediatr; 2015 Jan; 82(1):35-8. PubMed ID: 25065938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.
    Miyazaki T; Chiuve S; Sacks FM; Ridker PM; Libby P; Aikawa M
    PLoS One; 2014; 9(4):e94073. PubMed ID: 24705587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Plasma Pentraxin-3 Level with Lipid Levels and Cardiovascular Risk Factors in People with No History of Lipid-Lowering Medication: the Dong-gu Study.
    Lee R; Ahn HR; Shin MH; Kim HN; Lee YH; Choi SW; Kweon SS
    J Atheroscler Thromb; 2019 Aug; 26(8):738-745. PubMed ID: 30674758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome.
    Barazzoni R; Aleksova A; Carriere C; Cattin MR; Zanetti M; Vinci P; Stolfo D; Guarnieri G; Sinagra G
    Cardiovasc Diabetol; 2013 Nov; 12():167. PubMed ID: 24215445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise reduced pentraxin 3 levels produced by endotoxin-stimulated human peripheral blood mononuclear cells in obese individuals.
    Slusher AL; Shibata Y; Whitehurst M; Maharaj A; Quiles JM; Huang CJ
    Exp Biol Med (Maywood); 2017 Jun; 242(12):1279-1286. PubMed ID: 28440716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile.
    Zanetti M; Bosutti A; Ferreira C; Vinci P; Biolo G; Fonda M; Valente M; Cattin L; Guarnieri G; Barazzoni R
    Clin Exp Med; 2009 Sep; 9(3):243-8. PubMed ID: 19238513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study.
    Altay S; Çakmak HA; Kemaloğlu Öz T; Özpamuk Karadeniz F; Türer A; Erer HB; Kılıç GF; Keleş İ; Can G; Eren M
    Anatol J Cardiol; 2017 Mar; 17(3):202-209. PubMed ID: 27488759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients.
    Muller B; Peri G; Doni A; Torri V; Landmann R; Bottazzi B; Mantovani A
    Crit Care Med; 2001 Jul; 29(7):1404-7. PubMed ID: 11445697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers.
    Barazzoni R; Palmisano S; Gortan Cappellari G; Giuricin M; Moretti E; Vinci P; Semolic A; Guarnieri G; Zanetti M; Manzini Nd
    Surg Obes Relat Dis; 2016 Jan; 12(1):23-32. PubMed ID: 26277450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum pentraxin 3 levels are negatively associated with carotid intima media thickness in non-obese rheumatoid arthritis patients.
    Kahlow BS; Petisco R; Skare TL; Goeldner I; Nisihara RM; Messias-Reason IJ
    Int J Cardiol; 2016 Oct; 221():298-301. PubMed ID: 27404695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome.
    Ogawa T; Kawano Y; Imamura T; Kawakita K; Sagara M; Matsuo T; Kakitsubata Y; Ishikawa T; Kitamura K; Hatakeyama K; Asada Y; Kodama T
    Obesity (Silver Spring); 2010 Sep; 18(9):1871-4. PubMed ID: 20111016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
    Elshazly SA; Heiba NM; Abdelmageed WM
    Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of pentraxin 3 with insulin resistance and glucose response following maximal aerobic exercise in obese and normal-mass individuals.
    Slusher AL; Huang CJ
    Can J Physiol Pharmacol; 2016 Jul; 94(7):734-8. PubMed ID: 27152505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Schönlein purpura nephritis in children.
    Ge W; Wang HL; Sun RP
    Eur J Pediatr; 2014 Feb; 173(2):213-8. PubMed ID: 23963627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentraxin-3 as a marker of disease activity in Takayasu arteritis.
    Dagna L; Salvo F; Tiraboschi M; Bozzolo EP; Franchini S; Doglioni C; Manfredi AA; Baldissera E; Sabbadini MG
    Ann Intern Med; 2011 Oct; 155(7):425-33. PubMed ID: 21969341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PENTRAXIN 3 AS A NEW CARDIOVASCULAR MARKER IN ADRENAL ADENOMAS.
    Kizilgul M; Beysel S; Ozcelik O; Kan S; Apaydin M; Caliskan M; Ucan B; Sencar E; Ozdemir S; Cakal E
    Endocr Pract; 2017 Jun; 23(6):662-668. PubMed ID: 28332877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.
    Matsubara J; Sugiyama S; Nozaki T; Akiyama E; Matsuzawa Y; Kurokawa H; Maeda H; Fujisue K; Sugamura K; Yamamoto E; Matsui K; Jinnouchi H; Ogawa H
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25012287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations.
    Yamasaki K; Kurimura M; Kasai T; Sagara M; Kodama T; Inoue K
    Clin Chem Lab Med; 2009; 47(4):471-7. PubMed ID: 19327124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome.
    Bastrup-Birk S; Skjoedt MO; Munthe-Fog L; Strom JJ; Ma YJ; Garred P
    PLoS One; 2013; 8(9):e73119. PubMed ID: 24039869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Pentraxin 3 Fragment as a Noninvasive Marker of Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents.
    Hamza RT; Elfaramawy AA; Mahmoud NH
    Horm Res Paediatr; 2016; 86(1):11-20. PubMed ID: 27309736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.